RetaMaps

Retatrutide in Philadelphia, PA: status & local weight-loss providers

Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.

Phase 3 complete · Not FDA-approvedRetatrutide: Phase 3 complete · FDA submission planned Q1 2027 · Not available outside trials / expanded access. Tracker
39
tracked providers
6
advertise GLP-1 medications today
28
offer telehealth
10
have 100+ Google reviews

Anastassia Amaro, MD

3400 Civic Center Boulevard, Perelman Center for Advanced Medicine, West Pavilion, 4th Floor · Philadelphia, PA 19104

TelehealthAccepts insuranceSemaglutide today
View profileVisit website
Listing updated Oct 2, 2026

PhillyMedClub

1300 North 2nd Street · Philadelphia, PA 19122

5.0(202 Google reviews · 53 in past year)

TelehealthAccepts insuranceTirzepatide today
View profileBook / contact
Listing updated Oct 2, 2026

Pins reflect street addresses where available; others are approximate (ZIP-level).

Get retatrutide updates for Philadelphia

Nearby markets

Bala Cynwyd (1)Havertown (1)Bryn Mawr (3)Broomall (1)Elkins Park (1)Jenkintown (1)All of Pennsylvania →

Learn about retatrutide

FDA approval trackerWhat is retatrutide?When will retatrutide be available?

Frequently asked questions

Can I get retatrutide in Philadelphia today?

No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Philadelphia or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.

What do the providers listed for Philadelphia actually offer?

They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.

Are telehealth options tracked for Philadelphia?

Yes — 28 of the 39 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Pennsylvania residents; confirm with the practice.

Does being listed mean a Philadelphia provider will prescribe retatrutide?

No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.

How do I hear when availability changes near Philadelphia?

Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.